GlycoScreen receives CFI funding

A project spearheaded by GlycoNet principal investigators has received more than $3 million in funding from the Canada Foundation for Innovation’s Innovation Fund.

GlycoScreen: The Alberta-BC Glycan Screening Centre is a partnership between the University of Alberta, Simon Fraser University, and the University of Victoria to advance research in the field of glycomics. With funding support from the CFI and other partners, GlycoScreen will provide essential infrastructure needed for advanced research in glycomics.

Certain equipment in the areas of screening and analysis is necessary for the identification of glycan roles and functions. Residing at the three host institutions, and building on the infrastructure already in place, GlycoScreen will provide researchers with facilities and equipment to analyze glycans and to develop and optimize targets for drugs and diagnostics, making it a unique resource for regional, national and international glycomics researchers.

Glycomics is an emerging field that is rapidly expanding, particularly in Canada. GlycoScreen will boost Canada’s capacity for fundamental and applied research in glycomics, ultimately driving solutions to health problems.

The CFI’s Innovation Fund supports transformative research infrastructure projects that enable the discoveries and innovations that improve the lives of Canadians.